Electroretinography: Investigation of a Protocol Change

NCT ID: NCT03275441

Last Updated: 2017-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

262 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-31

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study evaluates whether an eye test called an electroretinogram (ERG) can be shortened and still produce the same diagnostic results. The results of this study may allow test times to be reduced which will have benefits such as improved patient compliance during shorter testing and increased clinic efficiency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A full-field electroretinogram (ERG) is a standardised eye test undertaken in specialist hospital clinics. ERGs are useful for diagnosing and monitoring retinal diseases. The retina is stimulated by showing patients flashes of light and the resulting electrical response from the eye is recorded using delicate electrodes that touch the surface of the eye. For the first section of the test, patient's eyes are allowed to adjust to the dark to ensure the parts of the retina responsible for seeing in dimly-lit conditions are being tested.

The international ERG Standard says patients must sit in the dark for 20 minutes. The investigators have evidence to suggest the test may be equally useful after only 10 minutes in the dark. The investigators plan to compare ERGs recorded from patients who have spent only 10 minutes in the dark with ERGs recorded from the same patients after the full 20 minutes in the dark. If the difference is suitably small, as found in a preliminary study of healthy individuals, it could be justifiable to shorten the routine patient protocol.

Subjects for this study will be recruited from the adult population routinely attending for an outpatient ERG test. During their routine ERG test, 10 minutes into the 20 minute wait in the dark, the investigators propose recording an additional, identical set of ERG tests. This will not add extra time to the clinical test.

Participants will not need any follow-up for the research study. The study requires 262 patients to test the hypothesis, and the investigators estimate this will take about 5-6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dark-adapted ERG

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients

Adult patients attending hospital for clinical visual electrophysiology.

Electroretinography

Intervention Type DIAGNOSTIC_TEST

An additional electroretinogram performed after 10 minutes of dark adaptation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electroretinography

An additional electroretinogram performed after 10 minutes of dark adaptation.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred to the adult visual electrophysiology service regardless of clinical condition, and who require dark-adapted electroretinography as part of their appointment
* Male or female
* All ethnicities

Exclusion Criteria

* Patients less than 18 years old
* Patients who might have difficulties understanding the participant information provided (for example, those patients requiring a translator, or who have learning difficulties)
* Patients with photosensitive epilepsy
* Patients appointed for clinical testing urgently, or via telephone, who will not have had an opportunity to receive and review the participant information sheet ahead of the clinical appointment.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

NHS Greater Glasgow and Clyde

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ruth Hamilton, PhD

Role: STUDY_DIRECTOR

NHS Greater Glasgow & Clyde

Kirsten Graham, MSc

Role: PRINCIPAL_INVESTIGATOR

NHS Greater Glasgow & Clyde

Richard Hagan, PhD

Role: PRINCIPAL_INVESTIGATOR

NHS Royal Liverpool University Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ruth Hamilton, PhD

Role: CONTACT

01414524217

Kirsten Graham, MSc

Role: CONTACT

01412112758

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GN17OP146

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epiretinal Membrane in Patients With DR.
NCT07241845 NOT_YET_RECRUITING
Dual Wavelength OCT
NCT03843840 COMPLETED
Functional Assessments in Vision Impairment
NCT06908161 NOT_YET_RECRUITING
Coloured-light in Retinitis Pigmentosa.
NCT06224114 NOT_YET_RECRUITING NA